Xencor XNCR
NASDAQ XNCR
$24.84 +0.07 (+0.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xencor (XNCR) Return on Sales [ROS] (2013 - 2026)

Updated

Xencor's Return on Sales [ROS] was -72.37% in Q2 2026, up 3.70 percentage points from -76.07% a year earlier and up 1651.77 percentage points from the prior quarter.

Analysis

Xencor (XNCR) Return on Sales [ROS] (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Xencor's Return on Sales [ROS] was -205.84% through Jun 30, 2026, down 107.34 percentage points year-over-year; for FY2025, it came in at -141.35%, up 20.12 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -78.76 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -161.47% in FY2024 (-85.66 pp), -75.80% in FY2023 (-25.70 pp), -50.11% in FY2022 (-66.01 pp) and 15.91% in FY2021 (+78.50 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q4 2024.
  • Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of -194.36 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2025 (a gain of 209.78 percentage points); the worst was Q1 2026 (a drop of 1592.21 percentage points).
  • Per Business Quant data, XNCR's Return on Sales [ROS] in the three quarters before Q2 2026 was -1724.14% (Q1 2026), -189.92% (Q4 2025) and -226.29% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Xencor 1.85 Bn 262.13 Mn - -72.37%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -72.37%
Mar 31, 2026 -1,724.14%
Dec 31, 2025 -189.92%
Sep 30, 2025 -226.29%
Jun 30, 2025 -76.07%
Mar 31, 2025 -131.93%
Dec 31, 2024 -24.96%
Sep 30, 2024 -310.17%
Jun 30, 2024 -231.61%
Mar 31, 2024 -341.71%
Dec 31, 2023 -53.67%
Sep 30, 2023 -30.86%
Jun 30, 2023 -57.11%
Mar 31, 2023 -319.71%
Dec 31, 2022 -197.19%
Sep 30, 2022 -140.47%
Jun 30, 2022 -92.72%
Mar 31, 2022 30.95%
Dec 31, 2021 59.51%
Sep 30, 2021 -209.64%
API Access

Xencor Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XNCR&period=max&api_key=YOUR_API_KEY